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Abstract
As a model of human hypoxia, exposure to high-altitude causes a number of
ventilatory, circulatory and hemopoietic adaptations. A review of literature on blood-
gas transport responses to hypoxia indicates that they are influenced not only by
altitude, but also by factors related to acclimatization. In addition, it appears that the
need to oxygenate tissues conflicts with the need to maintain H+ homeostasis. Thus, the
final situation represents a compromise between the respiratory adjustment aimed at
increasing blood alkalosis in order to optimize the oxygen transport system, and the
metabolic readjustment aimed at re-establishing normal blood pH. There are factors like
red cell 2,3-diphosphoglycerate, a compound that decreases the hemoglobin affinity for
oxygen, that can influence that balance by affecting arterial oxygen saturation through
mechanisms independent of respiration.
Introduction
Exposure to high altitude is associated to a number of physiological and pathological
responses. The first description of the deleterious effects of high altitude on humans
seems to date back to 30 B.C., when Tseen Han Shoo so described the journey along the
Silk Road in Karakorum: “The route from the Western regions to the Hindu Kush
crosses the Great Headache mountain, the Little Headache mountain, [where] men’s
body become feverish, lose color, and are attached with headache and vomiting” [1].
Since the 19th century, with the studies by Paul Bert, it is appreciated that altitude
problems stem out from the decreased barometric pressure, hence hypoxia.
If adaptation is defined as a change that reduces the physiological strain produced by
stressful aspects of the environment [2], it is either genotypic or phenotypic [3]. In the
latter case, it is also termed “acclimatization” [4]. Humans can adapt to hypoxia,
although less extensively than other mammals do [5], by establishing some degree of
compensation at several levels [6-8]. Briefly, at ventilatory level, hypoxic stimulation of
chemoreceptors causes an immediate increase of alveolar ventilation. The consequent
washout of large quantities of CO2 initially reduces arterial CO2 tension (PaCO2
† ) and
                                                
† ¶ List of abbreviations: AMS; acute mountain sickness; BE, base excess; DPG, 2,3-
diphosphoglycerate; Hb, hemoglobin; OEC, O2 equilibrium curve; PaCO2, arterial CO2
tension; PaO2, arterial O2 tension; pHa, arterial pH; PvO2, venous O2 tension; P50, PO2 at
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increases arterial pH (pHa). Subsequently, whereas the chemoreflexogenic
hyperventilatory response remains unchanged, pHa tends to return to near normal
levels as a consequence of HCO3
- loss through the kidney. At circulatory level, hypoxia
increases circulatory efficiency by three mechanisms: (1) immediate increase in cardiac
output, followed by a return to near normal levels in a few days; (2) increase of tissue
capillarity; (3) increase of the red cell concentration of 2,3-diphosphoglycerate (DPG), a
compound that decreases hemoglobin (Hb)-O2 affinity thereby enhancing O2 delivery to
tissue. At hemopoietic level, hypoxia stimulates spleen and bone marrow leading to: (1)
progressive increase of circulating hemoglobin over a period of several months (but the
advantage of increased blood O2 capacity are set off by increased blood viscosity); (2)
faster replacement of relatively “old” red blood cells by “young”, fresh red blood cells
with more favorable O2 transport characteristics. At metabolic level, although
mitochondria and cellular oxidative machinery are slightly more plentiful in some
animals native to altitude than in sea level controls, the importance of this adjustment in
humans is questionable and general consensus is now against this possibility [9].
Literature
The purpose of this brief review is to analyze the mechanisms underlying the response
of the gas transport system to hypoxia in resting subjects. Figure 1 shows a summary of
available literature [8,10-21]. Unless otherwise stated, the figure reports blood gas
transport data relative to Caucasian subjects exposed to real or simulated altitudes
>4300m, along with additional data referring to natives to the same or lower altitude, as
well as subjects with altitude-related disorders. The relevant data dispersion is caused by
the combination of the following features: (1) Difficult operating conditions in several
studies performed at altitude; (2) Different duration times of altitude exposure of the
subjects prior to analyses, from a few hours to several days or weeks; and (3)
unaccuracies in defining either altitude or barometric pressure. Actually, the equation
proposed by the International Civil Aviation Organization to derive the barometric
pressure from altitude:
  P P e RT
Mgh
=
−
0 /
where P0 is pressure at sea level, M is the average molecular weight of gas molecules, g
the acceleration of gravity, and h the height, provides a low guess of the real barometric
pressure. On the summit of Mt.Everest, this discrepancy accounts for up to 7% [22],
which has enormous implications for gas transport [23].
Despite data dispersion, decreasing trends are uniformly observed for arterial O2
tension (PaO2), arterial O2 saturation (SaO2) and PaCO2, whilst pHa and the blood molar
ratio [DPG]/[Hb] increase with altitude. In general, data taken under simulated altitude
conditions in hypobaric chambers [14,15] are within the limits of those taken under real
altitude conditions, with the exception of PaO2 and DPG.  Blood [Hb] always increases, a
common finding in all studies, but since it depends on both degree and duration of
hypoxia, this variable can not be conveniently plotted as a function of altitude. Indeed,
serum erhytropoietin peaks a few days after hypoxic exposure followed by progressive
                                                                                                                                                             
which half of hemoglobin is saturated with O2; SaO2, arterial O2 saturation; ∆O2(a-v),
arterial-to-venous O2 gradient.
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decrease during the following weeks, leading to maintained or slightly decreasing blood
[Hb] [24]. In addition, occurrence of striking differences among various populations
living at high altitudes also suggests presence of genetic-related patterns [25].
In this discussion, it is convenient to set an arbitrary altitude of ~4300m, roughly
corresponding to a reduction of inspired PO2 by one-half. Indeed, this altitude is near
the highest altitude to which man can be acclimatized and can live and perform work
for months [6]. Severe hypoxic stress prevents establishment of permanent human
settlings above 4500m, and induces >50% incidence of acute altitude-related disorders in
sojourners and trekkers [26]. Although it is questionable whether the process of human
adaptation to hypoxia would never be considered accomplished [8], it is also useful to
compare groups of subjects characterized by different degrees of adaptation. Indeed,
compensatory mechanisms may exist in individuals acclimatized to lower altitudes that
induce different responses during adaptation to higher altitudes. Whilst ~1% of world
population reside at altitudes exceeding 3300m [27], only two populations permanently
reside at altitudes up to 4300-4500m. Himalayan Sherpas are known as healthy, well-
adapted, virtually immune from altitude-related disorders [28]. In contrast, Andean
Quechuas apparently did not develop adaptation as shown from their higher
erythropoietic stimulus [29]. Finally, subjects suffering from acute mountain sickness
(AMS) [30] represent the case of failed acclimatization process. This failure helps to
understand the gas transport system at altitude as it does not involve other possibly
implicated systems as blood rheology and hence microcirculation [31].
Blood gases and acid-base balance
The PaO2 value progressively decreases with altitude. Whilst PaO2 in AMS subjects was
always lower than that of matched controls [16,18,21], the effects of acclimatization on
PaO2 are not clear. In one study, 18 days acclimatization to 4300m increased PaO2 [17].
Also, if American Indians are to be considered poorly adapted to hypoxia, then their
lower PaO2 with respect to Caucasians is not surprising [10]. However, another study
failed to observe any effect of 3 weeks adaptation to 5050m nor differences in PaO2 of
Sherpas and Caucasians acutely exposed to 6450m [21]. The ventilatory determinants of
PaO2, i.e., the gas exchange ratio and alveolar ventilation, are outside the limits of this
review, but, as originally pointed out, an adaptive reduction of alveolar-arterial O2
gradient in the course of acclimatization would represent an effective defense against
hypoxia [6]. Thus, the classical, now 25-years old hypothesis, that incomplete red cell
equilibration along the pulmonary capillary is crucial to determine PaO2, appears still
fully valid [32].
Graphical representation of the CO2 hydration reaction (H2O+CO2<=>H
++HCO3
-) by the
pH-HCO3
- diagram (Figure 2) shows that both volatile (CO2) and metabolic (H
+) factors
determine blood pH. The changes of the former follow the buffer lines, whilst changes
of the latter follow the iso-PCO2 curves. The base excess (BE, i.e., the amount of fixed H
+
that would have to be added to blood to titrate it to pH 7.4 at a PCO2 of 40 mmHg at
37°C [33]) helps to assess the contribution of metabolic H+ to acid-base imbalance: in the
-2 to +2 mEq/l range, altered PCO2 is the only contributor to acid-base imbalance;
otherwise, metabolic H+ is involved. In healthy humans, pHa is allowed to fluctuate
within a rather narrow range (7.35-7.45). The control systems that titrate pHa to its
normal value (7.40±0.02) are: (1) Body fluids buffer systems, which operate within
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fractions of second after the onset of the stimuli; (2) Ventilatory response (fast, but with
50-75% effectiveness); and (3) Metabolic compensation (slow, but powerful).
In humans exposed to hypoxia, the decrease of alveolar PO2 is accompanied by
decreasing alveolar PCO2 [34]. The hypothetical case of acute exposure to approximately
5000m is represented in the pH-HCO3
- diagram by moving from 1 to 2 along the buffer
line at BE=0 mEq/l. The effect of [Hb] on the slope of the buffer line is here neglected.
The resulting alkalinization triggers responses aimed at titrating blood pH back to 7.4,
but since the kidney is not able to fully accomplish this task at altitude, blood remains
alkaline (3 in the diagram). Perhaps this is due to the slowness of renal compensation
that can’t cope with continuous CO2 washout from the lungs, but the reasons for this
lack of compliance are not yet understood. Actually, at 6300-6450m, when considering
the increase of [Hb], BE was -6 mEq/l, whereas a BE of -10 to -9 mEq/l would have been
necessary for complete metabolic compensation [13,21].
Comparative analysis of the pH-PCO2 relationships in other groups of subjects helps to
assess the above issues. In Sherpas, PaCO2 is higher, and their pHa is lower than in
Caucasians [21]. As BE is comparable in the two groups, one can infer that less hypoxic
ventilatory drive in Sherpas [35] prevents excessive fall of PaCO2 and rise of alkalosis.
Probably, low DPG in Sherpas’ blood contributes to keep high SaO2 to a larger extent
than hyperventilation does in Caucasians. On the other hand, the high pHa value
estimated on a Mt.Everest summiter [13] is probably the consequence of extreme
hyperventilation that could have been beneficial for blood O2 loading. Indeed, this
subject had an extremely powerful ventilatory drive due to exercise and the need to
take off his oxygen mask 10 minutes before sampling [36]. Note also the steepness of
the pH-PCO2 relationship at low PCO2 values, which causes powerful increases of
alkalosis, particularly so under hypocapnic conditions [37]. At lower altitudes, subjects
who are characterized by altitude-related conditions also develop high pHa, likely
secondary to extreme hyperventilation and nearly uncompensated respiratory alkalosis.
The oxygen equilibrium curve
The main factors that influence the Hb-O2 equilibrium curve (OEC) are pH, PCO2 and
the [DPG]/[Hb] ratio. Here, Hb fenotype, temperature, and the level of carbonmonoxy-
Hb are irrelevant. Several studies in the past have already addressed the question on
how altitude alters OEC and hence P50, i.e., the PO2 at which Hb saturation for O2 is 50%
[5,6].
Red cell DPG is critical during hypoxia. A glycolytic intermediate occurring in all tissues,
only in the red cell DPG reachs sizeable concentrations. Hypoxia further increases DPG
by three mechanisms: (1) Preferential DPG binding to deoxygenated Hb [38] and high
levels of this Hb during hypoxia decrease free DPG levels thereby enhancing synthesis
[39]; (2) Alkalosis associated with hypoxia stimulates DPG mutase and inhibits DPG-
phosphatase [39]; (3) Hemopoietic stimulation increases the fraction of “young”, DPG-
rich red cells [19,24]. As a result of these synergisms, the [DPG]/[Hb] ratio always
increases with hypoxia, but Figure 1 shows that the dispersion of DPG data is much
higher than that observed for the other parameters. Possibly, the above mentioned
variability factors are complicated by additional problems as the time duration of
hypoxia, the degree of effort over the days or weeks before sampling, and technical
difficulties related to blood storage, extraction and enzymatic analysis with
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spectrophotometric methods. Indeed, since DPG is a rather unstable metabolite, the
blood sample should be obtained in suitable anticoagulant, and stored for no more than
a few hours at ice temperature before enzymatic analysis.
Increased DPG shifts the OEC to the right in antagonism with alkalosis. An algorithm
[40] allows to assess the effects of those factors on the OEC even under the extreme
conditions of pH, PCO2 and [DPG]/[Hb] found at high altitude: the discrepancy
between measured P50 and that calculated from the algorithm accounts for 0.2-0.4
mmHg [13]. In Caucasians at 6300m, the P50 value is higher than at sea level (29.8±2.2
mmHg [13] vs 27.5 mmHg [41]). Thus, the rightward shift caused by DPG appears
stronger than the leftward displacement caused by alkalosis. As a matter of fact, an
increase of the [DPG]/[Hb] molar ratio from 0.80 (sea level) to 1.36 (6450m [21]) would
have required an increase of pHa from 7.40 to 7.56 for complete compensation, i.e.,
much stronger alkalosis than actually measured. On the other hand, should alkalosis be
fully compensated by metabolic acidosis, thus offsetting the effect of pH, then P50 would
have been 33 mmHg.
There are very few data on DPG in altitude natives dwelling at altitudes >4300m, and
apparently no data at all for subjects with altitude-related disorders. However, in
Sherpas, the [DPG]/[Hb] ratio should be less than in Caucasians. Although at 3800m the
[DPG]/[Hb] ratio was the same in the two groups [29,42], at 5050m it was definitely
lower in Sherpas than in Caucasians (1.04±0.04 vs 1.28±0.05, respectively [24]). It is likely
that such trend does continue even at higher altitudes. In addition, when the
[DPG]/[Hb] ratio is calculated by the algorithm from actual Sherpas PaO2, PaCO2, pHa
and SaO2, it is estimated at ~1.2 [21].
Tuning of blood O2 transport
Blood OEC shifts are important to optimize the blood-O2 transport. The physiological
relevance of the OEC sigmoid shape is to maintain high arterial-to-venous O2 gradient
(∆O2(a-v)) at high venous PO2 (PvO2). High ∆O2(a-v) is favourable as, at the same work load,
it either decreases cardiac work or increases the O2 transport [43]. At sea level, assuming
constant PaO2 and PvO2 levels, rightward shifts of the OEC increase ∆O2(a-v) (Figure 3a)
because the venous point is located on the steep portion of the OEC. Therefore, small P50
increases reflect into considerable increases of ∆O2(a-v). Although this situation apparently
holds for moderate hypoxia (Figure 3b), it is reversed under severe hypoxia conditions,
where the arterial point lies in the steep portion of the OEC (Figure 3c). Under this
condition, the same P50 increase as in Figure 3a reflects in considerable decrease of ∆O2(a-v).
In theory, the threshold altitude above which a rightward shift of the OEC should be
regarded as a maladaptive response is near 5400m [44]. Thus, respiratory alkalosis is
favorable at extreme altitude: at 6450m, alkalosis increases SaO2 by at least 5% with
respect to an hypothetical non-alkalotic condition [21]. At 8848m, the extreme alkalosis
inferred in a Mt.Everest summiter should have allowed this subject to maintain
essentially same SaO2 as that measured at a much lower (2500m) altitude [13]. It is
therefore evident how the mechanism triggered by alkalosis maintains ∆O2(a-v) despite
low PaO2, thereby implying greater efficiency and lower load to the circulation.
Interestingly, theoretical considerations based on quite different principles, i.e., diffusion
limitations at the alveolar-capillary interface, point to the same conclusion: right shifts of
the OEC are favourable at sea level or moderate hypoxia, but not so at very high
altitude [45].
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Prolonged alkalosis, however, is not compatible with normal body function as it is
widely known to impair the central nervous system. Indeed, there appears to be a trend
towards less alkalosis with acclimatization: acclimatized subjects develop less alkalosis at
the same altitude, and AMS subjects are frankly alkalotic. Although it is not clear
whether altitude-related disorders stem from alkalosis or if the reverse is true, alkalosis
remains sustained even in subjects who do not experience AMS symptoms, but the
reasons for which alkalosis is deleterious at sea level, but is relatively well tolerated at
extreme altitude, are unknown. As a matter of fact, the most important action of a drug
used to fight the effect of AMS, i.e., acetozolamide, is to lower pHa by inhibiting the
enzyme carbonic anhydrase [27].
Conclusion
Analysis of the response of the blood-gas transport system to hypoxia indicates that, in
resting subjects, the need to oxygenate tissues conflicts with the need to maintain H+
homeostasis. In other words, at high altitude the cost of meeting tissue requirements for
O2 is competitive with other body functions, that may become progressively impaired
by alkalosis. The final situation represents a compromise between the respiratory
stimulus, which is aimed at increasing blood alkalosis in order to optimize the O2
tranport system, and the metabolic adjustment, which is aimed at re-establishing
normal blood pH. Factors like the [DPG]/[Hb] ratio influence that balance by affecting
SaO2 through mechanisms independent of respiration. Although metabolic and
ventilatory responses to exercise in moderate hypoxia are not subjected to genetic
influences [46], their role in determining the responses of the gas transport system to
extreme hypoxia is still to be evaluated.
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Legends to figures
Figure 1. Literature data of gas transport parameters at altitude >4300m in resting
subjects. Unless otherwise stated, data refer to Caucasian subjects exposed to altitude.
The curves represent the best fit obtained using only these data. SD bars are omitted for
clarity.
Figure 2. pH-bicarbonate diagram representing the situation at sea level (1), after the
respiratory response to acute exposure to approximately 5000m (2), and after partial
metabolic readjustment (3). The long-dashed lines represent the buffer lines at [Hb]=15
g/dl.
Figure 3. Effects of a rightward shift of the O2 equilibrium curve (~6 mmHg P50,
corresponding to an increase of the [DPG]/[Hb] ratio by 0.2 mole/mole) on the arterial-
to-venous O2 difference (∆O2). At sea level (3a) and at moderate hypoxia (3b), the shift
increases ∆O2, whilst this trend is reversed during severe hypoxia (3c). Further
explanations in the text.
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